Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Life Time Group Holdings Inc. Common Stock (LTH) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance

Life Time Group Holdings Inc. Common StockTrade
uniQure N.V. Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Life Time Group Holdings Inc. Common Stock vs uniQure N.V. Ordinary Shares — how do they compare? Life Time Group Holdings Inc. Common Stock trades at $40.07 (market cap $8.86B), while uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B). The key difference: Life Time Group Holdings Inc. Common Stock is far larger — about 6× uniQure N.V. Ordinary Shares's market cap, and Life Time Group Holdings Inc. Common Stock is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Life Time Group Holdings Inc. Common Stock for 6 Days and uniQure N.V. Ordinary Shares for 0 Days on average.

LTHQURE
Market Cap
$8.86B$1.48B
Volume
3,372,8852,488,780
Sector
Consumer CyclicalHealth
52-Week High
$45.73$70.59
52-Week Low
$24.59$9.03
Typical Hold Time
6 Days0 Days
Enterprise Value
$12.91B$728.62M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Life Time Group Holdings Inc. Common Stock

Life Time Group Holdings (LTH) trades at $39.66, down 1.76% today, amid bullish technical signals and strong fundamental performance. The stock shows consistent earnings beats, with Q2 2026 EPS of $0.48 exceeding expectations by 28%. Recent expansion news includes new athletic clubs in Florida and Boston, highlighting growth initiatives. Analyst consensus remains strongly bullish with an 86.7% buy rating and $55.17 price target, implying 39% upside.

LTH presents a compelling growth story with expanding facilities and robust profitability margins. Key risks include execution of expansion plans and consumer discretionary spending sensitivity. The valuation at 21.7x P/E appears reasonable given 13% net margins and double-digit ROE. Near-term catalyst is Q3 2026 earnings on October 29, 2026, which could validate the bullish analyst outlook.

uniQure N.V. Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LTH

No sentiment data available yet.

QURE
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Life Time Group Holdings Inc. Common Stock

Life Time operates fitness and lifestyle centers that offer gyms, classes, sports facilities, and wellness services.

Read more on LTH →

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →